In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

Acest lucru asigură că cashback-ul este urmărit corect și că ferestrele de înregistrare la turnee nu sunt ratate. Am văzut că jucătorii se descurcă jocul selly cel mai bine la Magic Jackpot Casino atunci când respectă un set de reguli pentru întreaga sesiune și iau puține decizii pe mână. Există rezumate ale regulilor chiar pe ecranul jocului, precum și un panou de ajutor pentru plăți și opțiuni secundare. Alege jocuri cu volatilitate scăzută spre medie și stai departe de jocurile care cumulează o mulțime de straturi bonus unul peste altul, dacă vrei sesiuni mai lungi, cu mai puține schimbări mari. Echipa noastră de servicii pentru clienți vă poate indica pagini de reguli, note RTP și explicații cu caracteristici secundare. În timp ce jucați jocurile de cazinou pe care doriți cu adevărat să le jucați. Depozitul minim, conversia maximă a bonusului și orice limite per rotire sunt toate afișate în casierie și în termenii de promovare pentru jucătorii de la România înainte de a face o depunere. În acest fel, puteți trece de la înscriere la joc imediat în cazinoul nostru.

Astfel, prima clasificare a acestor jocuri slot gratis ca la aparate cu fructe este realizată pe baza numărului de role prezente în fiecare joc casino, iar acest număr variază, în general, de la 3 la 5 role. Și dacă tot am adus în discuție fructele, multe dintre aceste jocuri online gratis dețin fructe și sunt cele mai cunoscute în domeniul de jocuri slot ca la aparate. Așadar, unele sloturi ca la aparate devin clasice datorită vechimii lor. Dacă simți că începi să pierzi prea mulți bani, dar totuși vrei să continui să te joci, poți să apelezi oricând la varianta de sloturi gratis ca la aparate. Pentru a te asigura că ai un stil de joc cât mai sănătos este important să citești secțiunea ”Joacă responsabil” și să ții cont de anumite reguli și limite pe care poți să le impui chiar tu. Scopul principal al acestor jocuri slot ca la aparate este de a te ajuta să te relaxezi, iar în timp ce faci asta, să îți aducă, de ce nu, câștiguri substanțiale.

Puteți vorbi cu echipa noastră de joc mai sigură despre jocurile dvs. Documentele oficiale, precum un act de identitate sau un pașaport românesc, sunt folosite pentru a vă dovedi vârsta și identitatea. Avem grijă de semne de risc, cum ar fi depozite mari, sesiuni lungi și încercări multiple de a ridica limitele. Când limita este coborâtă, coboară imediat, nu urcă niciodată. Dacă aveți nevoie de un bloc mai puternic, echipa noastră vă poate ajuta. Pentru a menține cazinoul echitabil, acest lucru oprește orice abuz care ar putea duce la fraudă sau spălare de bani. Puteți seta alerte pentru modificări mari și chitanțe de export cu marcaje temporale.

Agenții noștri vă pot spune de ce repere sunteți cel mai aproape și dacă activitatea dvs. Contactați asistența când sunteți gata și solicitați o verificare a eligibilității VIP. Alege-ți principalele tipuri de joc, joacă la mize similare și nu face multe schimbări de cont în interiorul cazinoului dacă vrei ca echipa noastră VIP de la Magic Jackpot Casino să-ți crească ofertele mai repede. Pot exista diferențe în metodele de depunere, timpii de procesare și limitele furnizorului dacă sunteți jucător de la românesc. Așa găsește echipa noastră jucători care merită o invitație rapidă. Asigurați-vă că titlurile pe care doriți să le introduceți sunt pe lista celor care sunt eligibile și nu întrerupeți sesiunile care se apropie de termenul limită. Clasamentele turneelor din cazinoul nostru nu se actualizează imediat, așa că nu folosiți cea mai recentă reîmprospătare pentru a vă da seama unde vă aflați.

Ofertă de bun venit: suplimentar Leu și rotiri gratuite

Cu numerar și carduri, transferurile pot avea loc imediat. Pentru sume mai mari, personalul poate cere să vadă actul de identitate. La sălile Magic Jackpot, majoritatea oamenilor încarcă și încasează cu numerar. Leul românesc (RON) este moneda pe care majoritatea afacerilor din România o folosesc ca monedă principală. Dacă un site sau un loc nu oferă informații clare despre licențiere, nu faceți un cont sau nu depuneți bani. Numărul de licență și sigiliul ONJN sunt de obicei afișate la ușa din față a locațiilor Magic Jackpot.